Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PRCH vs CURI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CURI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–3 Matrix Metrics)

CURI Overall Winner 6-Pillar Tally: PRCH 3 – 3 CURI Matrix Metrics: PRCH 3 – 6 CURI

As of Nov 16, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Porch Group, Inc. (PRCH) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PRCH carries a Unified Composite Score of 47.3/100 (HOLD) at $20.92 (62.6x Forward P/E, 8.0% operating margin), whereas CURI carries 36.5/100 (SELL) at $3.21 (8.7x Forward P/E, 10.1% operating margin).

  • Composite vs. Pillar Nuance: While PRCH currently prints a higher short-term Unified Composite Score (47.3/100 HOLD vs. CURI 36.5/100 SELL), CURI captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (10.1% vs. 8.0% operating margin) and revenue trajectory (+12.9% vs. +13.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PRCH vs CURI
PRCH NASDAQ
Porch Group, Inc. Common Stock
Services-Prepackaged Software
$20.92
-0.62% 1D
Market Cap $2.4B
TTM Revenue $530M
Forward P/E 62.6x
Beta / 30D Vol 1.59β · 114% Vol
Unified Composite Score
47.3 / 100 HOLD
Tech 26.0 Fund 45.0 Flow 55.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.6% over 20 days), RSI 58
RSI-14: 57.9 · SMA20: $19.83 · SMA50: $18.02
CURI NASDAQ Head-to-Head Winner
CuriosityStream Inc. Class A Common Stock
Services-Motion Picture & Video Tape Production
$3.21
+2.56% 1D
Market Cap $185.7M
TTM Revenue $78M
Forward P/E 8.7x
Beta / 30D Vol 1.29β · 94% Vol
Unified Composite Score
36.5 / 100 SELL
Tech 15.0 Fund 37.0 Flow 55.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 68
RSI-14: 67.6 · SMA20: $2.69 · SMA50: $2.77

6-Pillar Scorecard Institutional Category Breakdown (PRCH 3 – 3 CURI)

Columns: Metric · PRCH · CURI
1. Valuation Multiples CURI
Forward P/E 62.6x 8.7x
Trailing P/E N/M 20.9x
PEG Ratio N/M N/M
EV / Revenue 4.9x N/M
2. Growth & Scale PRCH
Revenue Growth (YoY) +13.0% +12.9%
Earnings Growth (YoY) +155.3% N/A
TTM Revenue (USD) $530M $78M
Market Cap $2.4B $185.7M
3. Profitability & Quality CURI
Gross Margin 72.1% 60.2%
Operating Margin 8.0% 10.1%
Net Profit Margin 1.8% 11.0%
Return on Equity (ROE) 5.6% 19.3%
4. Balance Sheet & Cash Flow CURI
Cash Generation (TTM) $99M $25M EBITDA
Cash Flow Margin 18.6% 31.9% EBITDA Mgn
Net Cash / Leverage $181M Net Debt (53.60x D/E) $631M Net Cash
Dividend Yield None (0.00%) 11.54%
5. Options & Positioning PRCH
Options Structure Phase BREAKOUT CONSOLIDATION
Current IV / %ile 63.6% (13th %ile) 99.3% (55th %ile)
Put/Call OI Skew 0.02x (Call-Skewed) 0.88x (Balanced)
OBV Trend / Tech Phase ACCUMULATION · Markup ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat PRCH
OpEx & R&D Intensity 64.1% of Rev ($340M) 50.1% of Rev ($39M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Insurance - Property & Casualty Operator Broadcasting Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PRCH (3) vs CURI (6)
Institutional Metric PRCH CURI Criterion Row Edge
Market Capitalization
Scale
$2.4B $185.7M Larger Scale PRCH
Trailing P/E Ratio
Valuation
N/M 20.9x Lower Multiple CURI
Forward P/E Ratio
Valuation
62.6x 8.7x Lower Multiple CURI
Revenue Growth (YoY)
Growth
+13.0% +12.9% Higher Growth Tie
Operating Margin (TTM)
Profitability
8.0% 10.1% Higher Margin CURI
Net Profit Margin
Profitability
1.8% 11.0% Higher Margin CURI
Return on Equity (ROE)
Capital Efficiency
5.6% 19.3% Higher ROE CURI
52-Week Range Position
Momentum
91% ($6–$22) 32% ($2–$5) Stronger Trend PRCH
Beta / 30D Volatility
Risk Regime
1.59β · 114% Vol 1.29β · 94% Vol Lower Realized Risk CURI
Unified Institutional Score
Composite Signal
47.3 / 100 (HOLD) 36.5 / 100 (SELL) Higher Composite PRCH
Trailing 12M Revenue (USD)
Operating Scale
$530M $78M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
72.1% 60.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.9x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$99M ($181M Net Debt (53.60x D/E)) $25M EBITDA ($631M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CURI +3.45 pp
PRCH: +19.54% · CURI: +22.99%
3M Horizon PRCH +13.18 pp
PRCH: +25.42% · CURI: +12.24%
6M Horizon PRCH +92.89 pp
PRCH: +109.83% · CURI: +16.94%
1Y Horizon PRCH +136.22 pp
PRCH: +105.1% · CURI: -31.12%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PRCH Revenue CURI Revenue PRCH Op. Margin CURI Op. Margin Margin Leader
FY2019 $80M $20M -113.6% -247.4% PRCH
FY2020 $70M $40M -58.4% -97.9% PRCH
FY2021 $190M $70M -43.3% -73.6% PRCH
FY2022 $280M $80M -64.2% -70.8% PRCH
FY2023 $290M $60M -66.2% -78.2% PRCH
FY2024 $310M $50M -20.6% -26.1% PRCH
FY2025 $420M $70M 8.7% -10.2% PRCH

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PRCH BREAKOUT
96d in phase · OBV ACCUMULATION
Current IV 63.6%
IV Percentile 13th %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact PRCH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CURI CONSOLIDATION
66d in phase · OBV ACCUMULATION
Current IV 99.3%
IV Percentile 55th %ile
Put/Call OI Skew 0.88x (Balanced)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CURI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PRCH Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $2.4B market capitalization and 8.0% operating margin.
OpEx & R&D Reinvestment 64.1% of Rev ($340M)
90D Engineering Disclosures 0 Published
CURI Moat Profile Scale & Operating Efficiency Moat
Broadcasting Operator
Competes within the Broadcasting value chain with $185.7M market capitalization and 10.1% operating margin.
OpEx & R&D Reinvestment 50.1% of Rev ($39M)
90D Engineering Disclosures 0 Published

Investor FAQ PRCH vs CURI Key Questions & Quantitative Answers

As of Nov 16, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Porch Group, Inc. (PRCH) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PRCH carries a Unified Composite Score of 47.3/100 (HOLD) at $20.92 (62.6x Forward P/E, 8.0% operating margin), whereas CURI carries 36.5/100 (SELL) at $3.21 (8.7x Forward P/E, 10.1% operating margin). Composite vs. Pillar Nuance: While PRCH currently prints a higher short-term Unified Composite Score (47.3/100 HOLD vs. CURI 36.5/100 SELL), CURI captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (10.1% vs. 8.0% operating margin) and revenue trajectory (+12.9% vs. +13.0% YoY).

PRCH leads the Growth & Scale pillar: PRCH posts +13.0% YoY revenue growth and +155.3% YoY earnings growth on $530M TTM revenue (72.1% gross margin, 8.0% operating margin), compared with CURI at +12.9% YoY revenue growth and N/A YoY earnings growth on $78M TTM revenue (60.2% gross margin, 10.1% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), PRCH cumulative revenue shifted +425.0% while CURI shifted +250.0%. In operating R&D and SG&A reinvestment, PRCH deploys 64.1% of Rev ($340M) (0 90-day corporate R&D disclosures) versus 50.1% of Rev ($39M) (0 disclosures) for CURI.

CURI screens cheaper on headline valuation multiples. PRCH trades at 62.6x Forward P/E, N/M Trailing P/E, N/M PEG, and 4.9x EV/Revenue (18.6% FCF margin), whereas CURI trades at 8.7x Forward P/E, 20.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (31.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PRCH (5.6% ROE) versus CURI (19.3% ROE) capital efficiency.

In options market volatility and institutional positioning, PRCH carries 63.6% implied volatility (13th %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.59β · 114% Vol realized risk). By comparison, CURI carries 99.3% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.88x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.29β · 94% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.